The TNF receptor superfamily in co-stimulating and co-inhibitory responses
Cytokines related to tumor necrosis factor (TNF) provide a communication network essential
for coordinating multiple cell types into an effective host defense system against pathogens …
for coordinating multiple cell types into an effective host defense system against pathogens …
High endothelial venules (HEVs) in immunity, inflammation and cancer
L Blanchard, JP Girard - Angiogenesis, 2021 - Springer
High endothelial venules (HEVs) are specialized blood vessels mediating lymphocyte
trafficking to lymph nodes (LNs) and other secondary lymphoid organs. By supporting high …
trafficking to lymph nodes (LNs) and other secondary lymphoid organs. By supporting high …
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
M Croft, RM Siegel - Nature Reviews Rheumatology, 2017 - nature.com
TNF blockers are highly efficacious at dampening inflammation and reducing symptoms in
rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing …
rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing …
Realigning the LIGHT signaling network to control dysregulated inflammation
CF Ware, M Croft, GA Neil - Journal of Experimental Medicine, 2022 - rupress.org
Advances in understanding the physiologic functions of the tumor necrosis factor
superfamily (TNFSF) of ligands, receptors, and signaling networks are providing deeper …
superfamily (TNFSF) of ligands, receptors, and signaling networks are providing deeper …
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing …
J Rodríguez-Carrio, A Burska, PG Conaghan… - RMD open, 2023 - rmdopen.bmj.com
Background Type I interferons (IFN-I) contribute to a broad range of rheumatic and
musculoskeletal diseases (RMDs). Compelling evidence suggests that the measurement of …
musculoskeletal diseases (RMDs). Compelling evidence suggests that the measurement of …
Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus
AC Labonte, B Kegerreis, NS Geraci, P Bachali… - PLoS …, 2018 - journals.plos.org
Systemic lupus erythematosus (SLE) is characterized by abnormalities in B cell and T cell
function, but the role of disturbances in the activation status of macrophages (Mϕ) has not …
function, but the role of disturbances in the activation status of macrophages (Mϕ) has not …
Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double …
EW St. Clair, AN Baer, C Wei, G Noaiseh… - Arthritis & …, 2018 - Wiley Online Library
Objective To evaluate the clinical efficacy and safety of baminercept, a lymphotoxin β
receptor IgG fusion protein (LT βR‐Ig), for the treatment of primary Sjögren's syndrome (SS) …
receptor IgG fusion protein (LT βR‐Ig), for the treatment of primary Sjögren's syndrome (SS) …
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE
WP Kennedy, R Maciuca, K Wolslegel… - Lupus science & …, 2015 - lupus.bmj.com
Objectives The interferon (IFN) signature (IS) in patients with systemic lupus erythematosus
(SLE) includes over 100 genes induced by type I IFN pathway activation. We developed a …
(SLE) includes over 100 genes induced by type I IFN pathway activation. We developed a …
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
Objectives To systematically review the literature for assay methods that aim to evaluate type
I interferon (IFN-I) pathway activation and to harmonise-related terminology. Methods Three …
I interferon (IFN-I) pathway activation and to harmonise-related terminology. Methods Three …
Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy
Tertiary lymphoid structures (TLS) often develop at sites of persistent inflammation, including
cancers and autoimmune diseases. In most cases, the presence of TLS correlates with …
cancers and autoimmune diseases. In most cases, the presence of TLS correlates with …